Intestinal Disorders News

These reports include research on the impact of the microbiome on obesity, asthma and COVID-19.

More frequent bowel movements were associated with increased incidence of diverticulitis, according to study results.

Anticoagulation use or antiplatelet agents were not risk factors for gastrointestinal bleeding in hospitalized COVID-19 patients, according to a study published in Journal of Internal Medicine.

Sebela Pharmaceuticals received FDA approval for its sulfate-based tablet preparation for colonoscopy.

The prevalence of constipation among women was two- to threefold higher during pregnancy and for the first few days postpartum, researchers wrote in the British Journal of Obstetrics and Gynecology.

Recently, the small intestine bacterial overgrowth breath test was launched by Cedars-Sinai to diagnose small intestine bacterial overgrowth related to irritable bowel syndrome.

Combination of Lactobacillus and Bifidobacterium were superior to single- and other multiple-strain probiotics and helped reduced all-cause mortality in preterm, low-birthweight infants, according to a meta-analysis published in Gastroenterology.

A clinical trial for a new treatment for short bowel syndrome is under way, according to the manufacturer, 9 Meters Bioparma.

Recently published study results showed that the bile acid sequestrant IW-3718 reduced heartburn and regurgitation symptoms in patients with refractory GERD.

Healthy women with long-term changes in plasma trimethylamine N-oxide, a choline metabolite produced from gut microbiota, had an increased risk for CHD, which may be modified by healthy dietary patterns, according to a prospective nested case-control study published in the Journal of the American College of Cardiology.